These findings suggest that MEOX1 may serve as a potential biomarker for ovarian cancer LNM diagnosis and treatment.473 In gastric cancer, RPRD1B promotes fatty acid uptake and synthesis, as well as LNM through activating the c-Jun/c-Fos/SREBP1 axis. Here, MEOX1 is linked to ovarian carcinoma.